Dec 09, 2019 / 01:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by and welcome to the Autolus ASH 2019 Data Investor Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Silvia Taylor, Vice President, Corporate Affairs and Communications. Please go ahead.
Silvia Taylor - Autolus Therapeutics plc - VP of Corporate Affairs & Communications
Thank you, Sarah. Good morning or good afternoon, everyone, and thank you for taking part in today's call to review the data highlights for Autolus' clinical data presented at the 2019 ASH Annual Meeting.
With me today is Dr. Christian Itin, our Chairman and Chief Executive Officer; and of course, Andrew Oakley, our CFO, is also with us.
Before we begin, I would like to remind you that during this call, we will be making forward-looking statements. All statements other than statements of historical facts contained in this presentation are forward-looking statements. Our actual results,
Autolus Therapeutics plc - Special Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot